Business Description
Encompass Health Corp
NAICS : 621498
SIC : 8093
ISIN : US29261A1007
Total Employee Number:
29,944Compare
Compare
Traded in other countries / regions
EHC.USAEHC.MexicoHSOA.Germany Index Membership
Russell 1000Russell 3000 IPO Date
1989-09-13Description
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.35 | |||||
Debt-to-Equity | 1.09 | |||||
Debt-to-EBITDA | 1.9 | |||||
Interest Coverage | 8.89 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 3.45 | |||||
Beneish M-Score | -2.78 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.3 | |||||
3-Year EBITDA Growth Rate | 16.6 | |||||
3-Year EPS without NRI Growth Rate | 24.1 | |||||
3-Year FCF Growth Rate | 52.5 | |||||
3-Year Book Growth Rate | 22.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 10.25 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 8.43 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 41.63 | |||||
9-Day RSI | 48.38 | |||||
14-Day RSI | 53.09 | |||||
3-1 Month Momentum % | 23.86 | |||||
6-1 Month Momentum % | 17.09 | |||||
12-1 Month Momentum % | -0.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.19 | |||||
Quick Ratio | 1.19 | |||||
Cash Ratio | 0.12 | |||||
Days Sales Outstanding | 37.71 | |||||
Days Payable | 257.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.63 | |||||
Dividend Payout Ratio | 0.13 | |||||
3-Year Dividend Growth Rate | -5.8 | |||||
Forward Dividend Yield % | 0.7 | |||||
5-Year Yield-on-Cost % | 0.34 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 2.48 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 95.82 | |||||
Operating Margin % | 18 | |||||
Net Margin % | 10.01 | |||||
EBITDA Margin % | 24.17 | |||||
FCF Margin % | 6.66 | |||||
OCF Margin % | 19.54 | |||||
ROE % | 25.43 | |||||
ROA % | 8.74 | |||||
ROIC % | 14.04 | |||||
3-Year ROIIC % | 27.47 | |||||
ROC (Joel Greenblatt) % | 26.22 | |||||
ROCE % | 18.43 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 9 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 19.41 | |||||
Forward PE Ratio | 17.84 | |||||
PE Ratio without NRI | 20.32 | |||||
Shiller PE Ratio | 27.33 | |||||
Price-to-Owner-Earnings | 31.34 | |||||
PEG Ratio | 1.65 | |||||
PS Ratio | 1.94 | |||||
PB Ratio | 4.53 | |||||
Price-to-Tangible-Book | 12.17 | |||||
Price-to-Free-Cash-Flow | 29.17 | |||||
Price-to-Operating-Cash-Flow | 9.95 | |||||
EV-to-EBIT | 13.31 | |||||
EV-to-Forward-EBIT | 13.54 | |||||
EV-to-EBITDA | 10.24 | |||||
EV-to-Forward-EBITDA | 10.02 | |||||
EV-to-Revenue | 2.47 | |||||
EV-to-Forward-Revenue | 2.11 | |||||
EV-to-FCF | 37.14 | |||||
Price-to-GF-Value | 1.04 | |||||
Price-to-Projected-FCF | 1.8 | |||||
Price-to-DCF (Earnings Based) | 1.65 | |||||
Price-to-DCF (FCF Based) | 2.54 | |||||
Price-to-Median-PS-Value | 1.42 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.76 | |||||
Price-to-Graham-Number | 3.33 | |||||
Earnings Yield (Greenblatt) % | 7.51 | |||||
FCF Yield % | 3.52 | |||||
Forward Rate of Return (Yacktman) % | 13.94 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:EHC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Encompass Health Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 6,206.1 | ||
| EPS (TTM) ($) | 6.14 | ||
| Beta | 0.5499 | ||
| 3-Year Sharpe Ratio | 0.66 | ||
| 3-Year Sortino Ratio | 1.02 | ||
| Volatility % | 30.63 | ||
| 14-Day RSI | 53.09 | ||
| 14-Day ATR ($) | 2.59237 | ||
| 20-Day SMA ($) | 121.746 | ||
| 12-1 Month Momentum % | -0.58 | ||
| 52-Week Range ($) | 92.77 - 127.99 | ||
| Shares Outstanding (Mil) | 98.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Encompass Health Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Encompass Health Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2027-02-26 | In 170 days | ||
| Fourth quarter earnings conference call for 2026 | 2027-02-05 10:00 | In 150 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-05 | In 149 days | ||
| Third quarter earnings conference call for 2026 | 2026-10-30 10:00 | In 52 days | ||
| Third quarter earnings results for 2026 | 2026-10-29 | In 50 days | ||
| USD 0.210000 Cash Dividend | 2026-10-01 | In 22 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-06 10:00 | 110.90 (-0.17%) | ||
| Second quarter earnings results for 2026 | 2026-08-05 | 110.50 (-0.67%) | ||
| USD 0.190000 Cash Dividend | 2026-07-01 | 101.08 (+0.35%) | ||
| Guidance call for 2026 | 2026-05-12 08:40 | 104.82 (-1.24%) |
Show
Entries
Encompass Health Corp Frequently Asked Questions
What is Encompass Health Corp(EHC)'s stock price today?
The current price of EHC is $119.16. The 52 week high of EHC is $127.99 and 52 week low is $92.77.
When is next earnings date of Encompass Health Corp(EHC)?
The next earnings date of Encompass Health Corp(EHC) is 2026-10-29 Est..
Does Encompass Health Corp(EHC) pay dividends? If so, how much?
The Dividend Yield %  of Encompass Health Corp(EHC) is 0.63% (As of Today), Highest Dividend Payout Ratio of Encompass Health Corp(EHC) was 0.39. The lowest was 0.13. And the median was 0.29. The  Forward Dividend Yield % of Encompass Health Corp(EHC) is 0.7%. For more information regarding to dividend, please check our Dividend Page.
Guru Commentaries on NYSE:EHC
2025 Q3
What the manager wrote
Encompass Health Corp. provides post-acute healthcare services including specialized rehabilitation treatment. The company continues to benefit from an aging population and a shortage of beds for inpatient rehabilitation, which positions it well for future growth. Although its share price edged forward by 4%, it fell short of the average index sector return of 8%. This indicates potential for improvement as the demand for rehabilitation services increases.
Madison Small Cap Fund
Bullish
2025 Q1
Madison Small Cap Fund
· 48 holdings
What the manager wrote
Encompass Health continues to benefit from strong demographic trends in its patient base and an attractive playbook for de novo facility expansion. This positions the company well for future growth as it capitalizes on the increasing demand for healthcare services. The fund's investment in Encompass Health reflects confidence in its ability to navigate the evolving healthcare landscape and deliver value to shareholders.
Press Release
Articles on Encompass Health Corp
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers